Scott Power
Stock Analyst at Morgans
(0.33)
# 4,471
Out of 5,014 analysts
234
Total ratings
34.6%
Success rate
-4.9%
Average return
Main Sectors:
Stocks Rated by Scott Power
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CGS Cogstate Limited | Reiterated: Buy | $4.07 | $3.41 | +19.35% | 1 | Sep 28, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $0.79 | $0.53 | +50.48% | 10 | Sep 10, 2026 | |
| ASX: IPD ImpediMed Limited | Downgraded: Hold | n/a | $0.005 | - | 33 | Aug 31, 2026 | |
| ASX: MX1 Micro-X Limited | Downgraded: Hold | $0.08 → $0.06 | $0.06 | +5.26% | 43 | Aug 31, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Buy | $3.36 → $3.19 | $2.59 | +23.17% | 9 | Aug 28, 2026 | |
| ASX: PNV PolyNovo Limited | Reiterated: Buy | $1.48 → $1.21 | $0.93 | +30.81% | 13 | Aug 27, 2026 | |
| ASX: TTX Tetratherix Limited | Reiterated: Buy | $8.59 | $6.30 | +36.35% | 10 | Aug 21, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $28.53 → $28.54 | $19.47 | +46.60% | 23 | Aug 20, 2026 | |
| ASX: BB1 BlinkLab Limited | Reiterated: Buy | $1.76 | $0.69 | +155.07% | 2 | Aug 11, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Reiterated: Buy | $2.94 → $2.90 | $1.59 | +82.97% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.85 → $0.05 | $0.06 | n/a | 8 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.32 | $2.94 | n/a | 18 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.55 | $0.24 | n/a | 18 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.09 → $1.20 | $0.75 | n/a | 19 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.33 → $1.89 | $4.31 | n/a | 12 | Dec 14, 2021 |
Cogstate Limited
Sep 28, 2026
Reiterated: Buy
Price Target: $4.07
Current: $3.41
Upside: +19.35%
Aroa Biosurgery Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $0.79
Current: $0.53
Upside: +50.48%
ImpediMed Limited
Aug 31, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.005
Upside: -
Micro-X Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.08 → $0.06
Current: $0.06
Upside: +5.26%
Sigma Healthcare Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $3.36 → $3.19
Current: $2.59
Upside: +23.17%
PolyNovo Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $1.48 → $1.21
Current: $0.93
Upside: +30.81%
Tetratherix Limited
Aug 21, 2026
Reiterated: Buy
Price Target: $8.59
Current: $6.30
Upside: +36.35%
EBOS Group Limited
Aug 20, 2026
Reiterated: Buy
Price Target: $28.53 → $28.54
Current: $19.47
Upside: +46.60%
BlinkLab Limited
Aug 11, 2026
Reiterated: Buy
Price Target: $1.76
Current: $0.69
Upside: +155.07%
Imricor Medical Systems, Inc.
Aug 11, 2026
Reiterated: Buy
Price Target: $2.94 → $2.90
Current: $1.59
Upside: +82.97%
Jan 8, 2024
Reiterated: Hold
Price Target: $0.85 → $0.05
Current: $0.06
Upside: n/a
Aug 23, 2023
Reiterated: Buy
Price Target: $5.43 → $5.32
Current: $2.94
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $1.55
Current: $0.24
Upside: n/a
Feb 18, 2022
Reiterated: Buy
Price Target: $1.09 → $1.20
Current: $0.75
Upside: n/a
Dec 14, 2021
Downgraded: Hold
Price Target: $2.33 → $1.89
Current: $4.31
Upside: n/a